ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 169 filers reported holding ANIKA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $493,000 | +26.7% | 10,900 | -0.9% | 0.02% | +30.8% |
Q3 2020 | $389,000 | -11.0% | 11,000 | -5.2% | 0.01% | +8.3% |
Q2 2020 | $437,000 | +23.8% | 11,600 | -4.9% | 0.01% | +9.1% |
Q1 2020 | $353,000 | -39.1% | 12,200 | +8.9% | 0.01% | -15.4% |
Q4 2019 | $580,000 | -35.6% | 11,200 | -31.7% | 0.01% | -35.0% |
Q3 2019 | $900,000 | +34.9% | 16,400 | 0.0% | 0.02% | +33.3% |
Q2 2019 | $667,000 | +866.7% | 16,400 | +465.5% | 0.02% | +400.0% |
Q3 2013 | $69,000 | – | 2,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |